These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4066618)

  • 1. Effects of clonidine in narcolepsy.
    Salín-Pascual R; de la Fuente JR; Fernández-Guardiola A
    J Clin Psychiatry; 1985 Dec; 46(12):528-31. PubMed ID: 4066618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the psychopharmacological management of the narcoleptic patient].
    Salín-Pascual RJ; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
    Rye DB; Dihenia B; Bliwise DL
    Depress Anxiety; 1998; 7(2):92-5. PubMed ID: 9614600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
    Mamelak M
    Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of clomipramine as an REM sleep suppressant in narcolepsy.
    Chen CN
    Postgrad Med J; 1980; 56 Suppl 1():86-9. PubMed ID: 7393833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
    Wyatt RJ; Fram DH; Buchbinder R; Snyder F
    N Engl J Med; 1971 Oct; 285(18):987-91. PubMed ID: 4328710
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REM changes in narcolepsy with selegiline.
    Reinish LW; MacFarlane JG; Sandor P; Shapiro CM
    Sleep; 1995 Jun; 18(5):362-7. PubMed ID: 7676170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic alternating pattern (CAP) alterations in narcolepsy.
    Terzano MG; Smerieri A; Del Felice A; Giglia F; Palomba V; Parrino L
    Sleep Med; 2006 Dec; 7(8):619-26. PubMed ID: 16740406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association.
    Sleep; 1994 Jun; 17(4):348-51. PubMed ID: 7973320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NREM sleep alterations in narcolepsy/cataplexy.
    Ferri R; Miano S; Bruni O; Vankova J; Nevsimalova S; Vandi S; Montagna P; Ferini-Strambi L; Plazzi G
    Clin Neurophysiol; 2005 Nov; 116(11):2675-84. PubMed ID: 16221567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [L-dopa therapy of narcolepsy. Observation of clinical course and polygraphic EEG night sleep and day leads].
    Kendel K; Rüther E; Beck U; Meier-Ewert K
    Nervenarzt; 1973 Aug; 44(8):434-6. PubMed ID: 4354849
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients.
    Jimerson DC; Post RM; Stoddard FJ; Gillin JC; Bunney WE
    Biol Psychiatry; 1980 Feb; 15(1):45-57. PubMed ID: 7357058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Narcolepsy: REM sleep suppression by L-dopa.
    Gilbert JC; Willer JC; Bernheim-Chaltelain C; Ecoffet M; Jaillon P
    N Engl J Med; 1976 Apr; 294(15):849. PubMed ID: 175275
    [No Abstract]   [Full Text] [Related]  

  • 19. Does memory impairment exist in narcolepsy-cataplexy?
    Aguirre M; Broughton R; Stuss D
    J Clin Exp Neuropsychol; 1985 Feb; 7(1):14-24. PubMed ID: 3980679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.
    Roth B; Faber J; Nevsímalová S; Tosovský J
    Schweiz Arch Neurol Neurochir Psychiatr; 1971; 108(2):251-60. PubMed ID: 4330752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.